Advanced Biomed Inc. Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement

Reuters

07-25

<a href="https://laohu8.com/S/ADVB">Advanced Biomed Inc.</a> Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement

Advanced Biomed Inc. has received a notice from Nasdaq indicating that the company's common stock has failed to meet the minimum bid price requirement of $1.00 per share for the past 32 consecutive business days. This notice, however, does not immediately affect the stock's listing or trading on the Nasdaq Capital Market, where it continues to trade under the symbol "ADVB." To comply with Nasdaq's Listing Rule 5550(a)(2), Advanced Biomed has until January 14, 2026, to raise its stock price to at least $1.00 for ten consecutive business days. If compliance is not achieved by this deadline, the company may qualify for an additional 180-day extension to meet listing standards, contingent on specific conditions. Advanced Biomed is actively exploring options to address this issue within the allotted timeframe.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-067328), on July 24, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2554807207"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554807207\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2554807207?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-25 04:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554807207","market":"nz","top_or_hot":-1,"title":"Advanced Biomed Inc. Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ADVB\">Advanced Biomed Inc.</a> Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Advanced Biomed Inc. has received a notice from Nasdaq indicating that the company's common stock has failed to meet the minimum bid price requirement of $1.00 per share for the past 32 consecutive business days. This notice, however, does not immediately affect the stock's listing or trading on the Nasdaq Capital Market, where it continues to trade under the symbol \"ADVB.\" To comply with Nasdaq's Listing Rule 5550(a)(2), Advanced Biomed has until January 14, 2026, to raise its stock price to at least $1.00 for ten consecutive business days. If compliance is not achieved by this deadline, the company may qualify for an additional 180-day extension to meet listing standards, contingent on specific conditions. Advanced Biomed is actively exploring options to address this issue within the allotted timeframe.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-067328), on July 24, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Advanced Biomed Inc. Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdvanced Biomed Inc. Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-25 04:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ADVB\">Advanced Biomed Inc.</a> Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Advanced Biomed Inc. has received a notice from Nasdaq indicating that the company's common stock has failed to meet the minimum bid price requirement of $1.00 per share for the past 32 consecutive business days. This notice, however, does not immediately affect the stock's listing or trading on the Nasdaq Capital Market, where it continues to trade under the symbol \"ADVB.\" To comply with Nasdaq's Listing Rule 5550(a)(2), Advanced Biomed has until January 14, 2026, to raise its stock price to at least $1.00 for ten consecutive business days. If compliance is not achieved by this deadline, the company may qualify for an additional 180-day extension to meet listing standards, contingent on specific conditions. Advanced Biomed is actively exploring options to address this issue within the allotted timeframe.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-067328), on July 24, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDL9yShlK:1","article_id":"2554807207","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554807207","pubTimestamp":1753387272,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Advanced Biomed Inc. has received a notice from Nasdaq indicating that the company's common stock has failed to meet the minimum bid price requirement of $1.00 per share for the past 32 consecutive business days. This notice, however, does not immediately affect the stock's listing or trading on the Nasdaq Capital Market, where it continues to trade under the symbol \"ADVB.\" To comply with Nasdaq's Listing Rule 5550, Advanced Biomed has until January 14, 2026, to raise its stock price to at least $1.00 for ten consecutive business days. If compliance is not achieved by this deadline, the company may qualify for an additional 180-day extension to meet listing standards, contingent on specific conditions. Advanced Biomed is actively exploring options to address this issue within the allotted timeframe.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","ADVB":"Advanced Biomed Inc."},"translate_title":"Advanced Biomed Inc.因低于最低投标价格要求而收到纳斯达克通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADVB":0.9},"content_text":"Advanced Biomed Inc. Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement\n    \n\n        Advanced Biomed Inc. has received a notice from Nasdaq indicating that the company's common stock has failed to meet the minimum bid price requirement of $1.00 per share for the past 32 consecutive business days. This notice, however, does not immediately affect the stock's listing or trading on the Nasdaq Capital Market, where it continues to trade under the symbol \"ADVB.\" To comply with Nasdaq's Listing Rule 5550(a)(2), Advanced Biomed has until January 14, 2026, to raise its stock price to at least $1.00 for ten consecutive business days. If compliance is not achieved by this deadline, the company may qualify for an additional 180-day extension to meet listing standards, contingent on specific conditions. Advanced Biomed is actively exploring options to address this issue within the allotted timeframe.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-067328), on July 24, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}